Case Report: Pan-Drug Resistant Pseudomonas aeruginosa from a Child with an Infected Burn Wound at the University Teaching Hospital of Kigali, Rwanda
Innocent Ndikubwimana,Noel Gahamanyi,Thaddée Bwanakweli,Henri Desire Uwayo,Gaspard Habimana,Tanya Rogo
DOI: https://doi.org/10.2147/idr.s486519
2024-10-25
Infection and Drug Resistance
Abstract:Innocent Ndikubwimana, 1 Noel Gahamanyi, 2, 3 Thaddée Bwanakweli, 2 Henri Desire Uwayo, 2 Gaspard Habimana, 4 Tanya Rogo 5 1 Pediatric Department, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda; 2 National Reference Laboratory, Rwanda Biomedical Centre, Kigali, Rwanda; 3 Biology Department, College of Science and Technology, University of Rwanda, Kigali, Rwanda; 4 Pediatric Department, Kigali University Teaching Hospital, Kigali, Rwanda; 5 Pediatric Infectious Diseases, Brown University Alpert Medical School, Providence, RI, USA Correspondence: Innocent Ndikubwimana, Email Background: Pseudomonas aeruginosa is a significant cause of morbidity and mortality in intensive care units, and is prevalent in nosocomial infections and cystic fibrosis. The increasing rates of antimicrobial resistance (AMR) complicate the treatment of P. aeruginosa infections, especially because of the multidrug resistance (MDR), extensively drug-resistant (XDR), and pan-drug resistant (PDR) strains. Case Presentation: We report the case of a 4-year-old male with severe burns covering 45% of his body surface who developed nosocomial PDR P. aeruginosa infection at the University Teaching Hospital of Kigali (CHUK) in Rwanda. A wound culture yielded a PDR P. aeruginosa isolate that was resistant to all the tested antimicrobials, with intermediate resistance to colistin. However, the patient improved with a combination of ceftazidime and amikacin following cessation of fever and successful skin grafting. The patient was discharged on day 95. Conclusion: P. aeruginosa is a common hospital-acquired pathogen that is particularly challenging to treat, owing to its antimicrobial resistance profile and biofilm production. Antibiotic-resistant strains are a significant public health threat, especially in pediatric burn units. This case underscores the critical need to strengthen infection prevention and control measures together with robust antimicrobial stewardship programs. Molecular characterization of this PDR strain will yield further details regarding its virulence and genotyping. Keywords: Pseudomonas aeruginosa , burn wound, antimicrobial resistance, CHUK, Rwanda Pseudomonas aeruginosa is among the major etiologies of morbidity and mortality in intensive care units, 1 and is known to predominate among nosocomial infections and cystic fibrosis cases. 2 Pseudomonas aeruginosa has the ability to survive under minimal nutritional requirements and can tolerate different disinfectant conditions, allowing it to persist on surfaces and facilitate hospital-acquired infections. 3 Additionally, P. aeruginosa has been associated with infections of the respiratory tract, skin, soft tissue, urinary tract, surgical sites, and the bloodstream. 4 Pseudomonas aeruginosa possesses an arsenal of virulence factors contributing to its adaptation to different environments and enable it to cause diseases. 5 These virulence factors empower P. aeruginosa to invade and colonize host cells and lead to clinical symptoms. This is done through interruption of host tissue integration, suppression of and escape from host immune response, and depletion of nutrients from the host. 5 Pseudomonas aeruginosa virulence factors are classified into surface structures (type IV pili and flagella, outer membrane components such as lipopolysaccharide, and five secretion systems (T1SS, T2SS, T3SS, T5SS, and T6SS), secreted factors (T1SS and T2SS), and bacterial cell-to-cell interaction (quorum sensing and biofilm). 6 The Lipopolysaccharide (LPS) is the first important surface structure which significantly decreases the membrane permeability. 7 The out-membrane proteins (OMPs) are involved in nutrient exchange, adhesion, and antibiotic resistance. 5 The formation of biofilms which associated with the flagellum, pili, and adhesions contribute to the drug resistance. 5 Over the past few decades, there has been a considerable increase in antimicrobial resistance (AMR), 5 known as the ability of microorganisms to nullify the effects of antimicrobials and render them ineffective. 8,9 This is complicated by the limited number of alternative antimicrobials effective against drug-resistant bacteria. 10 The treatment of P. aeruginosa infections is challenging because of their resistance to commonly used antimicrobials. 8,11 Multidrug resistance (MDR) is defined as resistance to at least three antibiotic classes, whereas extensive drug r -Abstract Truncated-
pharmacology & pharmacy,infectious diseases